ACE2 and hypertrophic cardiomyopathy: We used the induced pluripotent stem cells (iPSCs) generated from a male patient with hypertrophic cardiomyopathy (HCM)32 and analyzed ACE2 expression using western blotting and immunostaining after monolayer differentiation (Fig. 1a).